Promyelocytic Leukemia Nuclear Bodies [promyelocytická leukemická tělíska]
- Terms
-
jaderná doména 10
jaderná tělíska PML
ND 10
PML onkogenní doména
PML tělíska
PODs
promyelocytární leukemické tělísko
tělíska PML
-
PML Bodies
PML NBs
PML Nuclear Bodies
Promyelocytic Leukemia Nuclear Body
Promyelocytic Leukemia Protein Bodies
Promyelocytic Leukemia Protein Body
Spherical intranuclear membraneless bodies nucleated by PROMYELOCYTIC LEUKEMIA PROTEIN and various other proteins containing small ubiquitin-related modifier (SUMO) interaction motif (SIM) and/or sumoylated proteins (e.g., Sp100 protein). Promyelocytic leukemia nuclear bodies regulate posttranslational modifications of partner proteins (e.g., SUMOYLATION) which in turn lead to modulation of various biological processes.
- DUI
- D000088182 MeSH Browser
- CUI
- M000740236
- Previous indexing
- Intranuclear Inclusion Bodies (2008-2021); Promyelocytic Leukemia Protein (2008-2021)
- History note
- 2022
- Public note
- 2022
Allowable subheadings
- CH
- chemistry
- CL
- classification
- DE
- drug effects
- EN
- enzymology
- GE
- genetics
- IM
- immunology
- ME
- metabolism
- MI
- microbiology
- PS
- parasitology
- PA
- pathology
- PH
- physiology
- RE
- radiation effects
- TR
- transplantation
- UL
- ultrastructure
- VI
- virology